Mark L. Perry, Director at MyoKardia Inc (MYOK), bought 5,000 shares at $10.00 ($50K) on 2015-11-03, disclosed to the SEC on 2015-11-05.
Open-market purchase of $50k MYOK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NVDA | SELL | 2023-02-28 | $4.7M | — | Filing → |
| NVDA | SELL | 2022-03-21 | $5.6M | — | Filing → |
| NVDA | SELL | 2021-04-06 | $6.0M | — | Filing → |